SARS-CoV-2 Prion-Like Domains in Spike Proteins Enables Higher Affinity to ACE2

doi 10.20944/preprints202003.0422.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2

2020English

Composition and Divergence of Coronavirus Spike Proteins and Host ACE2 Receptors Predict Potential Intermediate Hosts of SARS-CoV-2

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

Energetics Based Modeling of Hydroxychloroquine and Azithromycin Binding to the SARS-CoV-2 Spike (S)Protein - ACE2 Complex

2020English

Human ACE2 Receptor Polymorphisms Predict SARS-CoV-2 Susceptibility

2020English

ACE2 Fragment as a Decoy for Novel SARS-Cov-2 Virus

2020English

In Silico Study of the Spike Protein From SARS-CoV-2 Interaction With ACE2: Similarity With SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism

2020English

The Effect of ACE2 Inhibitor MLN-4760 on the Interaction of SARS-CoV-2 Spike Protein With Human ACE2: A Molecular Dynamics Study

2020English

Potential Host Range of Multiple SARS-like Coronaviruses and an Improved ACE2-Fc Variant That Is Potent Against Both SARS-CoV-2 and SARS-CoV-1

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy